Association of a haplotype in the serotonin 5-HT4 receptor gene (HTR4) with Japanese schizophrenia

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 121 B, Issue 1, 2003, Pages 7-13

  Suzuki, T ^a   Iwata, Nakao ^a,d   Kitamura, Y ^b,c   Kitajima, T ^a   Yamanouchi, Y ^a   Ikeda, M ^a   Nishiyama, T ^a   Kamatani, N ^b   Ozaki, N ^a  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c MITSUBISHI RESEARCH INSTITUTE   (Japan)

^d FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Association study; Haplotype analysis; Schizophrenia; Serotonin 5 HT4 receptor single nucleotide polymorphism

Indexed keywords

ADENINE; CYTOSINE; GENE PRODUCT; GUANINE; SEROTONIN 4 RECEPTOR; THYMINE;

ALLELISM; ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE AMPLIFICATION; GENE FUNCTION; GENE HRT4; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRON; JAPAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DENATURATION; RECEPTOR GENE; RNA SPLICING; SCHIZOPHRENIA; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 0042320495     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.20060     Document Type: Article

References (28)

1. Altshuler D, Kruglyak L, Lander E. 1998. Genetic polymorphisms and disease. N Engl J Med 338:1626.
2. Andreasen NC, O'Leary DS, Cizadlo T, Arndt S, Rezai K, Ponto LL, Watkins GL, Hichwa RD. 1996. Schizophrenia and cognitive dysmetria: A positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry. Proc Natl Acad Sci USA 93:9985-9990.
3. Andreasen NC, Nopoulos P, O'Leary DS, Miller DD, Wassink T, Flaum M. 1999. Defining the phenotype of schizophrenia: Cognitive dysmetria and its neural mechanisms. Biol Psychiatry 46:908-920.
4. Bender E, Pindon A, van Oers I, Zhang YB, Gommeren W, Verhasselt P, Jurzak M, Leysen J, Luyten W. 2000. Structure of the human serotonin 5-HT4 receptor gene and cloning of a novel 5-HT4 splice variant. J Neurochem 74:478-489.
5. Bliss TV, Collingridge GL. 1993. A synaptic model of memory: Long-term potentiation in the hippocampus. Nature 361:31-39.
6. Blondel O, Gastineau M, Dahmoune Y, Langlois M, Fischmeister R. 1998. Cloning, expression, and pharmacology of four human 5-hydroxytryp-tamine 4 receptor isoforms produced by alternative splicing in the carboxyl terminus. J Neurochem 70:2252-2261.
7. Buhot MC. 1997. Serotonin receptors in cognitive behaviors. Curr Opin Neurobiol 7:243-254.
8. Buhot MC, Martin S, Segu L. 2000. Role ofserotonin in memory impairment. Ann Med 32:210-221.
9. Claeysen S, Sebben M, Becamel C, Bockaert J, Dumuis A. 1999. Novel brain-specific 5-HT4 receptor splice variants show marked constitutive activity: Role of the C-terminal intracellular domain. Mol Pharmacol 55:910-920.
10. Elvevag B, Goldberg TE. 2000. Cognitive impairment in schizophrenia is the core of the disorder. Crit Rev Neurobiol 14:1-21.
11. Gurling HM, Kalsi G, Brynjolfson J, Sigmundsson T, Sherrington R, Mankoo BS, Read T, Murphy P, Blaveri E, McQuillin A, Petursson H, Curtis D. 2001. Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. Am J Hum Genet 68:661-673.
12. Haliassos A, Chomel JC, Tesson L, Baudis M, Kruh J, Kaplan JC, Kitzis A. 1989. Modification of enzymatically amplified DNA for the detection of point mutations. Nucleic Acids Res 17:3606.
13. Hoogendoorn B, Owen MJ, Oefner PJ, Williams N, Austin J, O'Donovan MC. 1999. Genotyping single nucleotide polymorphisms by primer extension and high performance liquid chromatography. Hum Genet 104:89-93.
14. Kendler KS, Myers JM, O'Neill FA, Martin R, Murphy B, MacLean CJ, Walsh D, Straub RE. 2000. Clinical features of schizophrenia and linkage to chromosomes 5q, 6p, 8p, and 10p in the Irish study of high-density Schizophrenia families. Am J Psychiatry 157:402-408.
15. Kitamura Y, Moriguchi M, Kaneko H, Morisaki H, Morisaki T, Toyama K, Kamatani N. 2002. Determination ofprobability distribution of diplotype configuration (diplotype distribution) for each subject from genotypic data using the EM algorithm. Ann Hum Genet 66:183-193.
16. Kruglyak L. 1999. Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat Genet 22:139-144.
17. Letty S, Child R, Dumuis A, Pantaloni A, Bockaert J, Rondouin G. 1997. 5-HT4 receptors improve social olfactory memory in the rat. Neuropharmacology 36:681-687.
18. Levinson DF, Holmans P, Straub RE, Owen MJ, Wildenauer DB, Gejman PV, Pulver AE, Laurent C, Kendler KS, Walsh D, Norton N, Williams NM, Schwab SG, Lerer B, Mowry BJ, Sanders AR, Antonarakis SE, Blouin JL, DeLeuze JF, Mallet J. 2000. Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: Schizophrenia linkage collaborative group III. Am J Hum Genet 67:652-663.
19. Matsumoto M, Togashi H, Mori K, Ueno K, Ohashi S, Kojima T, Yoshioka M. 2001. Evidence for involvement of central 5-HT(4) receptors in cholinergic function associated with cognitive processes: Behavioral, electrophysiological, and neurochemical studies, J Pharmacol Exp Ther 296:676-682.
20. Medhurst AD, Lezoualc'h F, Fischmeister R, Middlemiss DN, Sanger GJ. 2001. Quantitative mRNA analysis of five C-terminal splice variants of the human 5-HT4 receptor in the central nervous system by TaqMan real time RT-PCR. Brain Res Mol Brain Res 90:125-134.
21. Ohashi J, Tokunaga K. 2001. The power of genome-wide association studies of complex disease genes: Statistical limitations of indirect approaches using SNP markers. J Hum Genet 46:478-482.
22. Otmakhova NA, Otmakhov N, Mortenson LH, Lisman JE. 2000. Inhibition of the cAMP pathway decreases early long-term potentiation at CA1 hippocampal synapses. J Neurosci 20:4446-4451.
23. Pritchard JK, Rosenberg NA. 1999. Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet 65:220-228.
24. Rotenberg A, Mayford M, Hawkins RD, Kandel ER, Muller RU. 1996. Mice expressing activated CaMKII lack low frequency LTP and do not form stable place cells in the CAl region of the hippocampus. Cell 87:1351-1361.
25. Sham PC, Curtis D. 1995. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 59(Pt 1):97-105.
26. Spiegelman JI, Mindrinos MN, Oefner PJ. 2000. High-accuracy DNA sequence variation screening by DHPLC. Biotechniques 29:1084-1090, 1092.
27. Vilaro MT, Domenech T, Palacios JM, Mengod G. 2002. Cloning and characterization of a novel human 5-HT4 receptor variant that lacks the alternatively spliced carboxy terminal exon. RT-PCR distribution in human brain and periphery of multiple 5-HT4 receptor variants. Neuropharmacology 42:60-73.
28. Weir BS. 1996. Geneic data analysis II. Sunderland, MA: Sinauer Associates.